Skip to main content
SpringerLink
Log in

Mechanisms of systemic inflammation associated with intestinal injury

  • Chapter
Inflammatory Bowel Disease: From Bench to Bedside

  • 1304 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Katz JP, Lichtenstein GR. Rheumatologic manifestations of gastrointestinal diseases. Gastroenterol Clin N Am 1998; 27: 533–62.

    CAS  Google Scholar 

  2. Leino R, Toivanen A. Arthritis associated with gastrointestinal disorders. In: Toivanen A, Toivanen P, eds. Reactive Arthritis. Boca Raton: CRC Press, 1988: 000

    Google Scholar 

  3. Jorizzo JL, Apisarnthanarax P, Subrt P et al. Bowel-bypass syndrome without bowel bypass. Arch Intern Med 1983; 143:457–61.

    PubMed  CAS  Google Scholar 

  4. Greenstein AJ, Janowitz HD, Sachar DB. The extraintestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine 1976; 55: 401–12.

    PubMed  CAS  Google Scholar 

  5. Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr. National Cooperative Crohn’s Disease Study: Extraintestinal manifestation and perianal complications. Gastroenterology 1979; 77: 914–20.

    PubMed  CAS  Google Scholar 

  6. Monsen U, Sorstad J, Hellers G, Johansson C. Extracolonic diagnoses in ulcerative colitis: an epidemiological study. Am J Gastroenterol. 1990; 85: 711–16.

    PubMed  CAS  Google Scholar 

  7. Jacobsen MB, Fausa O, Elgio K, Schrumpf E. Hepatic lesions in adult coeliac disease. Scand J Gastroenterol. 1990; 25: 656–62.

    PubMed  CAS  Google Scholar 

  8. Bourne JT, Kumar P, Huskisson EC, Mageed R, Unsworth IJ, Wojtulewski JA. Arthritis and celiac disease. Ann Rheum Dis 1985; 44: 592–8.

    PubMed  CAS  Google Scholar 

  9. Klein S, Mayer L, Present DH, Youner KD, Cerulli MA, Sachar DB. Extraintestinal manifestations in patients with diverticulitis. Ann Intern Med 1988; 108: 700–2.

    PubMed  CAS  Google Scholar 

  10. Toivanen A, Toivanen P. Reactive arthritis. Curr Opin Rheumatol 2000; 12: 300–5.

    PubMed  CAS  Google Scholar 

  11. Bocanegra TS, Espinoza LR, Bridgeford PH, Vasey FB, Germain BF. Reactive arthritis induced by parasitic infestation. Ann Intern Med 1981; 94: 207–9.

    PubMed  CAS  Google Scholar 

  12. Lichtman SN, Sartor RB, Keku J, Schwab JH. Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology 1990; 98: 414–23.

    PubMed  CAS  Google Scholar 

  13. Lichtman SN, Wang J, Sartor RB et al. Reactivation of arthritis induced by small bowel bacterial overgrowth in rats: role of cytokines, bacteria, and bacterial polymers. Infect Immun 1995; 63: 2295–301.

    PubMed  CAS  Google Scholar 

  14. Schultz M, Tonkonogy SL, Sellon RK et al. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol 1999; 276: G1461–72

    PubMed  CAS  Google Scholar 

  15. Sartor RB, Bender DE, Holt LC. Susceptibility of inbred rat strains to intestinal and extraintestinal inflammation induced by indomethacin. Gastroenterology 1 1992; 102: A690 (abstract).

    Google Scholar 

  16. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999; 10: 387–98.

    PubMed  CAS  Google Scholar 

  17. Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 1987; 22: 655–64.

    PubMed  CAS  Google Scholar 

  18. De Vos M, Cuvelier C, Mielants H, Veys E, Barbier F, Elewaut A. Ileocolonoscopy in seronegative spondylarthropathy. Gastroenterology 1989; 96: 339–44.

    PubMed  Google Scholar 

  19. Rabinovitz M, Gavaler JS, Schade RR, Dindzans VJ, Chien MC, Van Thiel DH. Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects. Hepatology 1990; 11: 7–11.

    PubMed  CAS  Google Scholar 

  20. Suh CH, Lee CH, Lee et al. Arthritic manifestations of inflammatory bowel disease. J Korean Med Sci 1998; 13: 39–43.

    PubMed  CAS  Google Scholar 

  21. Buskila D, Odes LR, Neumann L, Odes HS. Fibromyalgia in inflammatory bowel disease. J Rheumatol 1999; 26: 1167–171.

    PubMed  CAS  Google Scholar 

  22. Wright V, Watkinson G. The arthritis of ulcerative colitis. Medicine 1959; 38: 243–59.

    PubMed  CAS  Google Scholar 

  23. Olsson R, Danielsson A, Jarnerot G. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991; 100: 1319–23.

    PubMed  CAS  Google Scholar 

  24. Bardazzi G, Mannoni A, d’Albasio G et al. Spondyloarthritis in patients with ulcerative colitis. Italian J Gastroenterol Hepatol 1997; 29: 520–4.

    CAS  Google Scholar 

  25. Eastwood CJ Epidemic reactive arthritis. Ann Rheum Dis 1990; 49: 73–4.

    Google Scholar 

  26. Hermon-Taylor J, Bull TJ, Sheridan JM, Cheng J, Stellakis ML, Sumar N. Causation of Crohn’s disease by Mycobacterium avium subspecies paratuberculosis. Can J Gastroenterol 2000; 14: 521–39.

    PubMed  CAS  Google Scholar 

  27. Wakefield AJ, Montgomery SM, Pounder RE. Crohn’s disease: the case for measles virus. Ital J Gastroenterol Hepatol 1999; 31: 247–54.

    PubMed  CAS  Google Scholar 

  28. Ambrose NS, Johnson M, Burdon DW, Keighley MR. Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn’s disease surgery. Br J Surg 1984;71: 623–5.

    PubMed  CAS  Google Scholar 

  29. Brooke BN, Dykes PW, Walker FC. A study of liver disorder in ulcerative colitis. Postgrad Med J 1961; 37: 245–51.

    Google Scholar 

  30. Vinnik IE, Kern F, Struthers JE, Hill RB, Guzak S. Experimental chronic portal vein bacteremia. Proc Soc Exp Biol Med 1964; 15: 311–14.

    Google Scholar 

  31. Olsson R, Bjornsson E, Backman L et al. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J Hepatol 1998; 28: 426–32.

    PubMed  CAS  Google Scholar 

  32. Cox KL, Coc KM. Oral vancomycin treatment of PSC in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1998; 27: 580–3.

    PubMed  CAS  Google Scholar 

  33. Nilsson HO, Taneera J, Castedal M, Glatz E, Olsson R, Wadstrom T. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 2000; 38: 1072–6.

    PubMed  CAS  Google Scholar 

  34. Pearce CB, Duncan HD, Timmis L, Green JR. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2000; 12: 439–43.

    PubMed  CAS  Google Scholar 

  35. Foltz CJ, Fox JG, Cahill R et al. Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter 1998; 3: 69–78.

    PubMed  CAS  Google Scholar 

  36. Nilsson I, Lindgren S, Eriksson S, Wadstrom T. Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease. Gut 2000; 46: 410–14.

    PubMed  CAS  Google Scholar 

  37. Sherlock S. Pathogenesis of sclerosing cholangitis: the role of nonimmune factors. Semin Liver Dis 1991; 11: 5–10.

    PubMed  CAS  Google Scholar 

  38. Cello JP. Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease. Am J Med 1989; 86: 539–46.

    PubMed  CAS  Google Scholar 

  39. Chen XM, Levine SA, Tietz P et al. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology 1998; 28: 906–13.

    PubMed  CAS  Google Scholar 

  40. Narayanan Menon KV, Esner RH. Etiology and natural history of primary sclerosing cholangitis. J Hepato-Biliary-Pancreat Surg 1999; 6: 343–51.

    CAS  Google Scholar 

  41. Raj V, Lichtenstein DR. Hepatobiliary manifestations of inflammatory bowel disease. Gastroenterol Clin N Am 1999; 28: 491–513.

    CAS  Google Scholar 

  42. LaRusso NF. The Fifth Carlos E. Rubio Memorial Lecture. Sclerosing cholangitis: pathogenesis, pathology, and practice. PR Health Sci J 1999; 18: 11–17.

    CAS  Google Scholar 

  43. Granfors K, Jalkanen S, Essen RV. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989; 320: 216–21.

    PubMed  CAS  Google Scholar 

  44. Wordsworth BP, Hughes RA, Allan L, Keat AC, Bell JI. Chlamydial DNA is absent from joints of patients with sexually acquired reactive arthritis. Br J Rheumatol 1990; 29: 208–10.

    PubMed  CAS  Google Scholar 

  45. Thiel A, Wu P, Lauster R, Braun J, Radbruch A, Sieper J Analysis of the antigen-specific T cell response in reactive arthritis by flow cytometry. Arthritis Rheum 2000; 43: 2834–42.

    PubMed  CAS  Google Scholar 

  46. Yu DT. Pathogenesis of reactive arthritis. Intern Med 1999; 38:97–101.

    PubMed  CAS  Google Scholar 

  47. Wuorela M, Jal, Toivanen P, Granfors K. Intracellular pathogens and professional phagocytes in reactive arthritis. Pathobiology 1991; 59: 162–5.

    PubMed  CAS  Google Scholar 

  48. Rynes RI, Volastro PS, Bartholomew LE. Exacerbation of B27 positive spondyloarthropathy by enteric infections. J Rheumatol 1984; 11: 96–7.

    PubMed  CAS  Google Scholar 

  49. Wakefield D, McCluskey P, Verma M, Aziz K, Gatus B, Carr G. Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis. Arthritis Rheum 1999; 42: 1894–7.

    PubMed  CAS  Google Scholar 

  50. Hill JL, Yu DTY. Development of an experimental animal model for reactive arthritis induced by Yersinia enterocolitica infection. Infect Immun 1987; 55: 721–6.

    PubMed  CAS  Google Scholar 

  51. de los Toyos JR, Vazquez J, Sampedro A, Hardisson C. Yersinia enterocolitica serotype 0: 3 is arthritogenic for mice. Microb Pathogen 1990; 8: 370

    Google Scholar 

  52. Volkman A, Collins FM. Pathogenesis of Salmonella-associated arthritis in rats. Infect Immun 1975; 11: 222–30.

    PubMed  CAS  Google Scholar 

  53. Hermann E, Mayet WJ, Poralla T, Meyer zum Buschenfelde KH. Salmonella-reactive synovial fluid T cell clones in a patient with post-infectious Salmonella arthritis. Scand J Rheumatol 1990; 19: 350–5.

    PubMed  CAS  Google Scholar 

  54. Taurog JD, Richardson JA, Croft JT et al. The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 1994; 180: 2359–64.

    PubMed  CAS  Google Scholar 

  55. Rath HC, Herfarth HH, Ikeda JS et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B 27 /human beta2 microglobulin transgenic rats. J Clin Invest 1996; 98: 945–53.

    PubMed  CAS  Google Scholar 

  56. Driessen LHHM, van Saene HKF. A novel treatment of pyoderma gangrenosum by intestinal decontamination. Br J Dermatol 1983; 108: 108 (abstract).

    Google Scholar 

  57. Johnson LA, Wirostko E, Wirostko W. Parasitization of vitreous leukocytes by molliculte-like organisms. Am J Clin Pathol 1989; 91: 259–64.

    PubMed  CAS  Google Scholar 

  58. Wakefield D, Stahlberg TH, Toivanen A, Granfors K, Tennant C. Serologic evidence of Yersinia infection in patients with anterior uveitis. Arch Ophthalmol 1990; 108: 219–21.

    PubMed  CAS  Google Scholar 

  59. Sartor RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 1997; 92: 5S–11S.

    PubMed  CAS  Google Scholar 

  60. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182–205.

    PubMed  CAS  Google Scholar 

  61. Saarinen S, Olerup O, Broom U. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol 2000; 95: 3195–9.

    PubMed  CAS  Google Scholar 

  62. Koffler D, Minkowitz MD, Rothman W, Garlock J Immunocytochemical studies in ulcerative colitis and regional ileitis. J Exp Med 1962; 41: 733–41.

    CAS  Google Scholar 

  63. Chapman RW, Cottone M, Selby WS, Shepherd HA, Sherlock S, Jewell DP. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut 1986; 27: 86–91.

    PubMed  CAS  Google Scholar 

  64. Snook JA, Chapman RW, Fleming K, Jewell DP. Antineutrophil nuclear antibody in ulcerative colitis, Crohn’s disease and primary sclerosing cholangitis. Clin Exp Immunol 1989; 76: 30–3.

    PubMed  CAS  Google Scholar 

  65. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990; 86: 202–10.

    PubMed  CAS  Google Scholar 

  66. Roozendaal C, Kallenberg CG. Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)? Clin Exp Immunol 1999; 116: 206–13.

    PubMed  CAS  Google Scholar 

  67. Duerr RH, Targan SR, Landers CJ Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991; 100: 1385–91.

    PubMed  CAS  Google Scholar 

  68. Lindgren S, Nilsson S, Nassberger L, Verbaan H, Wieslander J Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK). J Gastroenterol Hepatol 2000; 15: 437–42.

    PubMed  CAS  Google Scholar 

  69. Orth T, Neurath M, Schirmacher P, Treichel U, Meyer zum Buschenfelde KH, Mayet W. Anti-neutrophil cytoplasmic antibodies in a rat model of TNBS acid-induced liver injury. Eur J Clin Invest 1999; 29: 929–39.

    PubMed  CAS  Google Scholar 

  70. Roozendaal C, van Milligen de Wit AW, Haagsma EB et al. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features. Am J Med 1998; 105: 393–9.

    PubMed  CAS  Google Scholar 

  71. Orth T, Kellner R, Diekmann O, Faust J, Meyer zum Buschenfelde BK, Mayet WJ Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis. Clin Exp Immunol 1998; 112: 507–15.

    PubMed  CAS  Google Scholar 

  72. Cohavy O, Bruckner D, Gordon LK et al. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun 2000; 68: 1542–8.

    PubMed  CAS  Google Scholar 

  73. Eggena M, Cohavy O, Parseghian MH et al. Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA. J Autoimmun 2000; 14: 83–97.

    PubMed  CAS  Google Scholar 

  74. Terjung B, Spengler U, Sauerbruch T, Worman HJ. ‘Atypical p-ANCA’ in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines. Gastroenterology 2000; 119: 310–22.

    PubMed  CAS  Google Scholar 

  75. Mieli-Vergani G, Lobo-Yeo A, McFarlane BM, McFarlane IG, Mowat AP, Vergani D. Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood. Hepatology 1989; 9: 198–203.

    PubMed  CAS  Google Scholar 

  76. McFarlane IG, Joycicka BM, Tsantoulas DC. Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis and other chronic liver diseases. Gastroenterology 1979; 76: 1333–40.

    PubMed  CAS  Google Scholar 

  77. Angulo P, Peter JB, Gershwin ME et al. Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol 2000; 32: 182–7.

    PubMed  CAS  Google Scholar 

  78. Das KM, Vecchi M, Sakamaki S. A shared and unique epitope(s) on human colon, skin and biliary epithelium detected by a monoclonal antibody. Gastroenterology 1990; 98: 464–9.

    PubMed  CAS  Google Scholar 

  79. Bhagat S, Das KM. A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody. Gastroenterology 1994; 107: 103–8.

    PubMed  CAS  Google Scholar 

  80. Geng X, Biancone L, Dai HH et al. Tropomyosin isoforms in intestinal mucosa: production of autoantibodics to tropomyosin isoforms in ulcerative colitis. Gastroenterology 1998; 114: 912–22.

    PubMed  CAS  Google Scholar 

  81. Mandal A, Dasgupta A, Jeffers L et al. Autoantibodics in sclerosing cholangitis against a shared peptide in biliary and colon epithelium. Gastroenterology 1994; 106: 185–92.

    PubMed  CAS  Google Scholar 

  82. Takahashi F, Das KM. Isolation and characterization of a colonic autoantigen specifically recognized by colon tissue-bound immunoglobulin G from idiopathic ulcerative colitis. Clin Invest 1985; 76: 311–18.

    CAS  Google Scholar 

  83. Sakamaki S, Takayanagi N, Yoshizaki N et al. Autoantibodies against the specific epitope of human tropomyosin(s) detected by a peptide based enzyme immunoassay in sera of patients with ulcerative colitis show antibody dependent cell mediated cytotoxicity against HLA-DPw9 transfected L cells. Gut 2000; 47: 236–41.

    PubMed  CAS  Google Scholar 

  84. Biancone L, Monteleone G, Marasco R, Pallone F. Autoimmunity to tropomyosin isoforms in ulcerative colitis (UC) patients and unaffected relatives. Clin Exp Immunol 1998; 113: 198–205.

    PubMed  CAS  Google Scholar 

  85. Ohman L, Franzen L, Rudolph U, Harriman GR, Hultgren HE. Immune activation in the intestinal mucosa before the onset of colitis in Galphai2-deficient mice. Scand J Immunol 2000; 52: 80–90.

    PubMed  CAS  Google Scholar 

  86. Mizoguchi A, Mizoguchi E, Chiba C et al. Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease. J Exp Med 1996; 183:847–56.

    PubMed  CAS  Google Scholar 

  87. Khoo UY, Bjarnason I, Donaghy A, Williams R, Macpherson A. Antibodies to colonic epithelial cells from the serum and colonic mucosal washings in ulcerative colitis. Gut 1995; 37: 63–70.

    PubMed  CAS  Google Scholar 

  88. Ueno Y, Phillips JO, Ludwig J, Lichtman SN, LaRusso NF. Development and characterization of a rodent model of immune-mediated cholangitis. Proc Natl Acad Sci USA 1996; 93: 216–20.

    PubMed  CAS  Google Scholar 

  89. Ueno Y, Ishii M, Takahashi S, Igarashi T, Toyota T, LaRusso NF. Different susceptibility of mice to immune-mediated cholangitis induced by immunization with carbonic anhydrase. Lab Invest 1998; 78: 629–37.

    PubMed  CAS  Google Scholar 

  90. Gordon SC, Quattrociocchi-Longe TM, Khan BA et al. Antibodies to carbonic anhydrase in patients with immune cholangiopathies. Gastroenterology 1995; 108: 1802–9.

    PubMed  CAS  Google Scholar 

  91. Broome U, Grunewald J, Scheynius A, Olerup O, Hultcrantz R. Preferential V beta3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis. J Hepatol 1997; 26: 527–34.

    PubMed  CAS  Google Scholar 

  92. Alpini G, Galsser SS, Ueno Y et al. Heterogenicity of the proliferative capacity of rat cholangiocytes after bile duct ligation. Am J Physiol 1998; 274: G767–75.

    PubMed  CAS  Google Scholar 

  93. Nonomura A, Kono N, Minato H, Nakanuma Y. Diffuse biliary tract involvement mimicking primary sclerosing cholangitis in an experimental model of chronic graftversus-host disease in mice. Pathol Int 1998; 48: 421–7.

    PubMed  CAS  Google Scholar 

  94. Howell CD, Yodre T, Claman HN, Vierling JM. Hepatic homing of mononuclear cells isolated during murine chronic graft-vs-host disease. J Immunol 1989; 143: 476–83.

    PubMed  CAS  Google Scholar 

  95. Ueno Y, Ishii M, Yahagi K et al. Fas-mediated cholangiopathy in the murine model of graft versus host disease. Hepatology 2000; 31: 966–74.

    PubMed  CAS  Google Scholar 

  96. Shalaby MR, Fendly B, Sheehan KC Schreiber RD, Ammann AJ Prevention of the graft-vs-host reaction in newborn mice by antibodies to tumor necrosis factor-alpha. Transplantation 1989; 47: 1057–61.

    PubMed  CAS  Google Scholar 

  97. van der Brink MRM, Moore E, Horndasch KJ et al. Fas-deficient lpr mice are more susceptible to graft-vs-host disease. J Immunol 2000; 164: 469–80.

    Google Scholar 

  98. Dienes HP, Lohse AW, Gerken G et al. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Archiv 1997; 431: 119–24.

    PubMed  CAS  Google Scholar 

  99. Yu DTY, Choo SY, Schaack T. Molecular mimicry in HLA-B27 related arthritis. Ann Intern Med 1989; 111: 581–91.

    PubMed  CAS  Google Scholar 

  100. Lopez-Larrea C, Gonzalez S, Martinez-Borra J The role of HLA-B27 polymorphism and molecular mimicry in spondyloarthropathy. Mol Med Today 1998; 4: 540–9.

    PubMed  CAS  Google Scholar 

  101. Chou CT, Uksila J, Toivanen P. Entcrobacterial antibodies in Chinese patients with rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol 1998; 16: 161–4.

    PubMed  CAS  Google Scholar 

  102. Tsuchiya N, Husby G, Williams RC, Stieglitz H, Lipsky PE, Inman RD. Autoantibodies to the HLA B27 sequence crossroad with the hypothetical peptide from the arthritis associated Shigella plasmid. J Clin Invest 1990; 86: 1193–203.

    PubMed  CAS  Google Scholar 

  103. Tsuchiya N, Husby G, Williams RC. Antibodies to the peptide from the plasmid coded Yersinia outer membrane protein (YOPI) in patients with ankylosing spondylitis. Clin Exp Immunol 1990; 82: 493–8.

    PubMed  CAS  Google Scholar 

  104. Zhou M, Sayad A, Simmons WA et al. The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats. J Exp Med 1998; 188: 877–86.

    PubMed  CAS  Google Scholar 

  105. Khare SD, Bull MJ, Hanson J, Luthra HS, David CS. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides. J Immunol 1998; 160: 101–6.

    PubMed  CAS  Google Scholar 

  106. Khare SD, Lee S, Bull MJ et al. Peptide binding alpha 1 alpha2 domain of HLA-B27 contributes to the disease pathogenesis in transgenic mice. Hum Immunol 1999; 60: 116–26.

    PubMed  CAS  Google Scholar 

  107. Breban M, Hammer RE, Richardson JA, Taurog JD. Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med 1993; 178:1607–16.

    PubMed  CAS  Google Scholar 

  108. Hermann E, Lohse AW, van der Zee R. Synovial fluid-derived Yersinia reactive T cells responding to human 65 kDa heat shock protein and heat stressed antigen presenting cells. Eur J Immunol 1991; 21: 2139–43.

    PubMed  CAS  Google Scholar 

  109. Kaufmann SH. Heat shock proteins and the immune response. Immunol Today 1990; 11: 129–36.

    PubMed  CAS  Google Scholar 

  110. Winrow VR, Mojdehi GM, Ryder SD, Rhodes JM, Blake DR, Rampton DS. Stress proteins in colorectal mucosa. Enhanced expression in ulcerative colitis. Dig Dis Sci 1993; 38: 1994–2000.

    PubMed  CAS  Google Scholar 

  111. Baca-Estrada ME, Gupta RS, Stead RH, Croitoru K. Intestinal expression and cellular immune responses to human heat-shock protein 60 in Crohn’s disease. Dig Dis Sci 1994; 39: 498–506.

    PubMed  CAS  Google Scholar 

  112. van den Broek MF, Hogervorst EJ, van Bruggen MC, Van Eden W, van der Zee R, van den Berg WB. Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein. J Exp Med 1989; 170: 449–66.

    PubMed  Google Scholar 

  113. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC. Identification of self peptides bound to purified HLA-B27. Nature 1991; 353: 326–9.

    PubMed  CAS  Google Scholar 

  114. Steinhoff U, Brinkmann V, Klemm U et al. Autoimmune intestinal pathology induced by hsp60-specific CD8 T cells. Immunity 1999; 11:349–58.

    PubMed  CAS  Google Scholar 

  115. Mertz AK, Wu P, Sturniolo T et al. Multispecific CD4+ T cell response to a single 12-mer epitope of the immunodominant heat-shock protein 60 of Yersinia enterocolitica in Yersinia-triggered reactive arthritis: overlap with the B27-restricted CD8 epitope, functional properties, and epitope presentation by multiple DR alleles. J Immunol 2000; 164: 1529–37.

    PubMed  CAS  Google Scholar 

  116. Giant TT, Mikecz K. Antiproteoglycan antibodies in experimental spondyloarthritis. In: Kresina TF, ed. Monoclonal Antibodies, Cytokines, and Arthritis. New York: Marcel Dekker, 1991.

    Google Scholar 

  117. van den Broek MF, van de Putte LB, van den Berg WB. Crohn’s disease associated with arthritis: a possible role for crossreactivity between gut bacteria and cartilage in the pathogenesis of arthritis. Arthritis Rheum 1988; 31: 1077–9.

    PubMed  Google Scholar 

  118. Broberger O, Perlmann P. Autoantibodies in human ulcerative colitis. J Exp Med 1959; 110: 657–74.

    PubMed  CAS  Google Scholar 

  119. Labeille B, Gineston JL, Denoeux JP, Capron JP. Epidermolysis bullosa acquisita and Crohn’s disease. Arch Intern Med 1988; 148: 1457–9.

    PubMed  CAS  Google Scholar 

  120. Gordon LK, Eggena M, Holland GN, Weisz JM, Braun J pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis. J Clin Immunol 1998; 18: 264–71.

    PubMed  CAS  Google Scholar 

  121. Singh VL, Donoso LA, Yamaki K, Shinohara T. Uveitopathogenic sites in bovines antigen. Autoimmunity 1989; 3: 177–87.

    PubMed  CAS  Google Scholar 

  122. Li Q, Sun B, Dastgheib K, Chan CC. Suppressive effect of transforming growth factor beta1 on the recurrence of experimental melanin protein-induced uveitis: upregulation of ocular interleukin-10. Clin Immunol Immunopathol 1996; 81: 55–61.

    PubMed  CAS  Google Scholar 

  123. Becker MD, Adamus G, Davey MP, Rosenbaum JT. The role of T cells in autoimmune uveitis. Ocular Immunol Inflamm 2000; 8: 93–100.

    CAS  Google Scholar 

  124. Altman AR, Maltz C, Janowitz HD. Autoimmune hemolytic anemia in ulcerative colitis. Dig Dis Sci 1979; 24: 282–5.

    PubMed  CAS  Google Scholar 

  125. Stevens C, Peppercorn MA, Janowitz HD. Crohn’s disease associated with autoimmune neutropenia. J Clin Gastroenterol 1991; 13:328–30.

    PubMed  CAS  Google Scholar 

  126. Soltis RD, Hasz D, Morris MJ, Wilson ID. Evidence against the presence of circulating immune complexes in chronic inflammatory bowel disease. Gastroenterology 1979; 76: 1380–5.

    PubMed  CAS  Google Scholar 

  127. Lawley TJ, James SP, Jones EA. Circulating immune complexes: their detection and potential significance in some hepatobiliary and intestinal diseases. Gastroenterology 1980; 76: 626–41.

    Google Scholar 

  128. Hodgson HJ, Potter BJ, Jewell DP. Immune complexes in ulcerative colitis and Crohn’s disease. Clin Exp Immunol 1977; 29: 187–96.

    PubMed  CAS  Google Scholar 

  129. Lake AM, Stitzel AE, Urmson JR, Walker WA, Spitzer RE. Complement alterations in inflammatory bowel disease. Gastroenterology 1979; 76: 1374–9.

    PubMed  CAS  Google Scholar 

  130. Bodenheimer HC, LaRusso NF, Thayer WR, Charland C, Staples PJ, Ludwig J Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 1983; 3: 150–4.

    PubMed  Google Scholar 

  131. Alberti-Flor JJ, Medina M, Jeffeers L, Schif TER. Elevated immunoglobulins and immune complexes in the bile of patients with primary sclerosing cholangitis. Hepatology 1983; 3: 844 (abstract).

    Google Scholar 

  132. Senaldi G, Donaldson PT, Magrin S et al. Activation of the complement system in primary sclerosing cholangitis. Gastroenterology 1989; 97: 1430–4.

    PubMed  CAS  Google Scholar 

  133. Minuk GY, Angus M, Brickman CM et al. Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. Gastroenterology 1985; 88: 166–70.

    PubMed  CAS  Google Scholar 

  134. Wands JR, LaMont JT, Mann E, Isselbacher KJ Arthritis associated with intestinal bypass procedure for morbid obesity. N Engl J Med 1976; 294: 121–4.

    PubMed  CAS  Google Scholar 

  135. Utsinger PD. Systemic immune complex disease following intestinal bypass surgery: bypass disease. J Am Dermatol 1980; 2: 488–95.

    CAS  Google Scholar 

  136. Zapanta M, Aldo-Benson M, Madura J Clinical and immunological features in patients with postintestinal bypass arthritis. Arthritis Rheum 1978; 21: 599 (abstract).

    Google Scholar 

  137. Lahesmaa-Rantala R, Granfors K, Isomaki H, Toivanen A. Yersinia specific immune complexes in the synovial fluid of patients with Yersinia triggered reactive arthritis. Ann Rheum Dis 1987; 46: 510–14.

    PubMed  CAS  Google Scholar 

  138. Peeters AJ, Warmold A, Van den Wall Bake L, Van Albada-Kuipers GA. IgA containing immune complexes and hematuria in ankylosing spondylitis. A prospective longitudinal study. J Rheumatol 1988; 15: 1662–7.

    PubMed  CAS  Google Scholar 

  139. Peeters AJ, Van den Wall Bake AWL, Daha MR, Breedveld FC. Inflammatory bowel disease and ankylosing spondylitis associated with cutaneous vasculitis, glomerulonephritis, and circulating IgA immune complexes. Ann Rheum Dis 1990; 49: 638–40.

    PubMed  CAS  Google Scholar 

  140. Sandborn WJ, Hanauer SB. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety. Inflam Bowel Dis 1999; 5:119–33.

    CAS  Google Scholar 

  141. Mayer L, Meyers S, Janowitz HD. Cryoproteinemia in the cutaneous gangrene of Crohn’s disease: a report of two cases. J Clin Gastroenterol 1981; 3: 17–21.

    PubMed  Google Scholar 

  142. Stein HB, Otto LA, Schlappner WB, Gourlay RH, Reeve CE. The intestinal bypass arthritis dermatitis syndrome. Arthritis Rheum 1981; 24: 684–90.

    PubMed  CAS  Google Scholar 

  143. Shum DT, Guenther L. Metastatic Crohn’s disease. Arch Dermatol 1990; 126: 6455–8.

    Google Scholar 

  144. Wakefield AJ, Sankey EA, Dhillon AP, Sawyer AFM. Granulomatous vasculitis in Crohn’s disease. Gastroenterology 1991; 100: 1279–87.

    PubMed  CAS  Google Scholar 

  145. de Kozak Y. Antibody response in uveitis. Eye 1997; 11: 194–9.

    PubMed  Google Scholar 

  146. Sartor RB. Microbial factors in the pathogenesis of Crohn’s disease, ulcerative colitis and experimental intestinal inflammation. In: Kirsner JB, ed. Inflammatory Bowel Diseases: 5th edition. Philadelphia: W.B. Saunders, 1999: 153–78.

    Google Scholar 

  147. Sartor RB. Intestinal microflora in human and experimental inflammatory bowel disease. Curr Opin Gastroenterol 2001;17 (In press).

    Google Scholar 

  148. Sartor RB, Veltkamp C. Interactions between enteric bacteria and the immune system which determine mucosal homeostasis vs chronic intestinal inflammation: Lessons from rodent models. In: Rogler G, Kullmann F, Rutgeerts P, Sartor RB, Scholmerich J, eds. IBD at the End of Its First Century. Dordrecht: Kluwer Academic Publishers, 2000: 30–41.

    Google Scholar 

  149. Katz KD, Hollander D, Vanheim CM. Intestinal permeability in patients with Crohn’s disease and their healthy relatives. Gastroenterology 1989; 97: 927–31.

    PubMed  CAS  Google Scholar 

  150. Wellmann W, Fink PC, Benner F, Schmidt FW. Endotoxaemia in active Crohn’s disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut 1986; 27: 814–20.

    PubMed  CAS  Google Scholar 

  151. Kruis W, Schussler P, Weinzierl M, Galanos C, Eisenburg J Circulating lipid A antibodies despite absence of systemic endotoxemia in patients with Crohn’s disease. Dig Dis Sci 1984; 29: 502–7.

    PubMed  CAS  Google Scholar 

  152. Anderson RP, Friend GM, Ferry DM, Chadwick VS. Formyl peptidemia in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gastroenterology 1991; 100: A557 (abstract).

    Google Scholar 

  153. Hobson CH, Butt TJ, Ferry DM, Hunter J, Chadwick VS, Broom MF. Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis. Gastroenter ology 1988; 94: 1006–13.

    CAS  Google Scholar 

  154. Anderson RP, Butt TJ, Chadwick VS. Hepatobiliary excretion of bacterial formyl-methionyl peptides in rat. Structure activity studies. Dig Dis Sci 1992; 37: 248–56.

    PubMed  CAS  Google Scholar 

  155. Sartor RB, Bond TM, Schwab JH. Systemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury. Infect Immun 1988; 56: 2101–8.

    PubMed  CAS  Google Scholar 

  156. Veltkamp C, Tonkonogy SL, de Yong Y et al. Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in TG epsilon 26 mice after bone marrow transplantation or adoptive transfer. Gastroenterology 2001; 120: 913

    Google Scholar 

  157. Yamada T, Sartor RB, Marshall S, Specian RD, Grisham MB. Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterology 1993; 104:759–71.

    PubMed  CAS  Google Scholar 

  158. Sartor RB, DeLa Cadena RA, Green KD et al. Selective kallikrcin kinin system activation in inbred rats differentially susceptible to granulomatous enterocolitis. Gastroenterology 1996; 110: 1467–81.

    PubMed  CAS  Google Scholar 

  159. Anton PA, Targan SR, Shanahan F. Increased neutrophil receptors for and response to the proinflammatory bacterial peptide formyl-methionyl-leucyl-phenylalanine in Crohn’s disease. Gastroenterology 1989; 97: 20–8.

    PubMed  CAS  Google Scholar 

  160. Stimpson SA, Esser RE, Carter PB, Sartor RB, Cromartie, WJ, Schwab JH. Lipopolysaccharide induces recurrence of arthritis in rat joints previously injured by peptidoglycan-polysaccharide. J Exp Med 1987; 165: 1688–702.

    PubMed  CAS  Google Scholar 

  161. Kono K, Kunihiko O, Masao O. Experimental portal fibrosis produced by intraportal injection of killed non-pathogenic Escherichia coli in rabbits. Gastroenterology 1990; 98: 414–23.

    Google Scholar 

  162. Buttery LD, Evans TJ, Springall DR, Carpenter A, Cohen J, Polak JM. Immunochemical localization of inducible nitric oxide synthase in endotoxin-treated rats. Lab Invest 1994; 71: 755–64.

    PubMed  CAS  Google Scholar 

  163. Park J, Gores GJ, Patel T. Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6-mediated activation of p44/p42 mitogen-activated protein kinase. Hepatology 1999; 29: 1037–43.

    PubMed  CAS  Google Scholar 

  164. Yamada S, Ishii M, Kisara N, Nagatomi R, Toyota T. Macrophages are essential for lymphocyte infiltration in formyl peptide-induced cholangitis in liver. Liver 1999; 19: 253–8.

    PubMed  CAS  Google Scholar 

  165. Lichtman SN, Keku J, Clark RL, Schwab JH, Sartor RB. Biliary tract disease in rats with experimental small bowel bacterial overgrowth. Hepatology 1991; 13: 766–72.

    PubMed  CAS  Google Scholar 

  166. Lichtman SN, Keku J, Schwab JH, Sartor RB. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology 1991; 100: 513–19.

    PubMed  CAS  Google Scholar 

  167. Lichtman SN, Keku J, Schwab JH, Sartor RB. Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth. Infect Immun 1991; 59: 555–62.

    PubMed  CAS  Google Scholar 

  168. Lichtman SN, Sartor RB, Schwab JH. Elimination of peptidoglycan polysaccharide in rat bile. Gastroenterology 1988; 94: 262A (abstract).

    Google Scholar 

  169. Lichtman SN, Okoruwa EE, Keku J, Schwab JH, Sartor RB. Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth. J Clin Invest 1992; 90: 1313–22.

    PubMed  CAS  Google Scholar 

  170. Wahl SM, Allen JB, Dougherty S. T lymphocyte dependent evolution of bacterial cell wall induced hepatic granulomas. J Immunol 1986; 137: 2199–209.

    PubMed  CAS  Google Scholar 

  171. Manthey CL, Kossmann T, Allen JB, Corcoran ML, Brandes ME, Wahl SM. Role of Kupffer cells in developing streptococcal cell wall granulomas. Am J Pathol 1992; 140: 1205–14.

    PubMed  CAS  Google Scholar 

  172. Sasatomi K, Noguchi K, Sakisaka S, Sata M, Tanikawa K. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 1998; 29: 409–16.

    PubMed  CAS  Google Scholar 

  173. Lichtman SN, Bharucha A, Jorgcnsen R, Lindor KD. Evidence that the bacterial cell wall polymer, peptidogly-can-polysaccharide, plays a role in primary sclerosing cholangitis. Gastroenterology 1998; 114: A1290 (abstract).

    Google Scholar 

  174. Gardiner KR, Halliday MI, Barclay GR et al. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 1995; 36: 897–901.

    PubMed  CAS  Google Scholar 

  175. Ely PH. The bowel bypass syndrome: a response to bacterial peptidoglycans. J Am Acad Dcrmatol 1980; 2: 473–87.

    CAS  Google Scholar 

  176. Park H, Schumacher HR, Zeigler AR. Antibodies to peptidoglycan in patients with spondyloarthritis: a clue to disease etiology? Ann Rheum Dis 1984; 43: 725–8.

    PubMed  CAS  Google Scholar 

  177. Rahman MU, Ahmed S, Schumacher R, Zeigler AR. High levels of antipeptidoglycan antibodies psoriatic and other seronegative arthritides. J Rheumatol 1990; 17: 621–5.

    PubMed  CAS  Google Scholar 

  178. Onderdonk AB, Richardson JA, Hammer RE, Taurog JD. Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infect Immun 1998; 66: 6022–3.

    PubMed  CAS  Google Scholar 

  179. Rath HC, Wilson KH, Sartor RB. Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus and Escherichia coli. Infect Immun 1999; 67: 2969–74.

    PubMed  CAS  Google Scholar 

  180. Khare SD, Luthra HS, David CS. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. J Exp Med 1995; 182: 1153–8.

    PubMed  CAS  Google Scholar 

  181. Stimpson SA, Schwab JH. Chronic remittent erosive arthritis induced by bacterial peptidoglycan polysaccharide structures. In: Chang JY, Lewis AJ, eds. Pharmacological Methods in the Control of Inflammation. New York: Alan R. Liss, 1989:381–94.

    Google Scholar 

  182. Cromartie WJ, Craddock JG, Schwab JH, Anderle SK, Yang CH. Arthritis in rats after systemic injection of streptococcal cells or cell walls. J Exp Med 1977; 146: 1585–602.

    PubMed  CAS  Google Scholar 

  183. Stimpson SA, Brown RR, Anderle SK et al. Arthropathic properties of cell wall polymers from normal flora bacteria. Infect Immun 1986; 51: 240–9.

    PubMed  CAS  Google Scholar 

  184. Severijnen AJ, Hazenberg MP, van de Murwe JP. Induction of chronic arthritis in rats by cell wall fragments of anaerobic coccoid rods isolated from the faecal flora of patients with Crohn’s disease. Digestion 1988; 39: 118–25.

    PubMed  CAS  Google Scholar 

  185. Zhang X, Rimpilainen M, Simelyte E, Toivanen P. What determines arthritogenicity of bacterial cell wall? A study on 167. Eubacterium cell wall-induced arthritis. Rheumatology (Oxf.) 2000; 39: 274–82.

    PubMed  CAS  Google Scholar 

  186. Yoshino S, Sasatomi E, Mori Y, Sagai M. Oral administration of lipopolysaccharide exacerbates collagen-induced arthritis in mice. J Immunol 1999; 163: 3417–22.

    PubMed  CAS  Google Scholar 

  187. Lichtman SN, Bachmann S, Munoz SR et al. Bacterial cell wall polymers (peptidoglycan-polysaccharide) cause reactivation of arthritis. Infect Immun 1993; 61: 4645–53.

    PubMed  CAS  Google Scholar 

  188. Stoughton RB. Enzymatic cytolysis of epithelium by filtrates from patients with ulcerative colitis. Invest Dermatol 1953; 20: 353–6.

    CAS  Google Scholar 

  189. Cromartie WJ, Anderle SK, Schwab JH, Dalldorf FG. Experimental arthritis, carditis and pinnitis induced by systemic injection of group A streptococcal cell walls into guinea pigs. In: Parker MT, ed. Proceedings of the Ninth International Symposium on Streptococci and Streptococcal diseases. Windsor: Reedbooks, 1978: 50–2.

    Google Scholar 

  190. Ohanian SH, Schwab JH. Persistence of group A streptococcal cell walls related to chronic inflammation of rabbit dermal connective tissue. J Exp Med 1967; 125: 1137–48.

    PubMed  CAS  Google Scholar 

  191. Rosebaum JT, McDevitt HO, Guss RB, Egbert PR. Endotoxin induced uveitis in rats as a model for human disease. Nature 1980; 286: 611–13.

    Google Scholar 

  192. Wells A, Pararajasegaram G, Baldwin M, Yang CH, Hammer M, Fox A. Uveitis and arthritis induced by systemic injection of streptococcal cell walls. Invest Ophthalmol Vis Sci (PA) 1986; 27: 921–5.

    PubMed  CAS  Google Scholar 

  193. Merino G, Fujino Y, Hanashiro RK. Lipoteichoic acid as an inducer of acute uveitis in the rat. Invest Ophthalmol Vis Sci 1998; 39: 1251–6.

    PubMed  CAS  Google Scholar 

  194. Waksman BH, Bullington SJ Studies of arthritis and other lesions induced in rats by ingestion of mycobacterial adjuvant. Arch Ophthalmol 1960; 64: 751–61.

    PubMed  CAS  Google Scholar 

  195. Baggia S, Lyons JL, Angell E et al. A novel model of bacterially-induced acute anterior uveitis in rats and the lack of effect from HLA-B27 expression. J Invest Med 1997; 45: 295–301.

    CAS  Google Scholar 

  196. Shen DF, Chang MA, Matteson DM, Buggage R, Kozhich AT, Chan CC. Biphasic ocular inflammatory response to endotoxin-induced uveitis in the mouse. Arch Ophthalmol 2000; 118: 521–7.

    PubMed  CAS  Google Scholar 

  197. Sartor RB, Anderle SK, Rifai N, Goo DA, Cromartie WJ, Schwab JH. Protracted anemia associated with chronic, relapsing systemic inflammation induced by arthropathic peptidoglycan-polysaccharide polymers in rats. Infect Immun 1989; 57: 1177–85.

    PubMed  CAS  Google Scholar 

  198. Sartor RB. Pathogenetic and clinical relevance of cytokines in inflammatory bowel disease. Immunol Res 1991; 10: 465–71.

    PubMed  CAS  Google Scholar 

  199. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, MacDonald TT. Serum concentrations of tumour necrosis factor a in childhood chronic inflammatory bowel disease. Gut 1991; 32: 913–17.

    PubMed  CAS  Google Scholar 

  200. Tracey KJ, Wei H, Manogue KR. Cachectin tumor necrosis factor induces cachexia, anemia and inflammation. J Exp Med 1988; 167: 1211–27.

    PubMed  CAS  Google Scholar 

  201. Otterness IG, Golden HW, Brissette WH, Saymour PA, Daumy GO. Effects of continuously administered murine interleukin la: tolerance development and granuloma formation. Infect Immun 1989; 57: 2742–50.

    PubMed  CAS  Google Scholar 

  202. Lichtman SN, Wang J, Reinstein JL, Lemasters JJ Role of TNFα in causing hepatobiliary injury in rats with experimental small bowel bacterial overgrowth. In: Knook DL, Wisse E, eds. Cells of the Hepatic Sinusoid. Leiden: Kupffer Cell Foundation, 1993: 141–2.

    Google Scholar 

  203. Bharucha AE, Jorgensen R, Lichtman SN, LaRusso NF, Lindor KD. A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis. Am J Gastroenterol 2000; 95: 2338–42.

    PubMed  CAS  Google Scholar 

  204. Kaminski DL. Arachidonic acid metabolites in hepatobiliary physiology and disease. Gastroenterology 1989; 97: 781–92.

    PubMed  CAS  Google Scholar 

  205. Wahl SM. Cellular and molecular interactions in the induction of inflammation in rheumatic diseases. In: Kresina TF, ed. Monoclonal Antibodies, Cytokines, and Arthritis. New York: Marcel Dekker, 1991.

    Google Scholar 

  206. Schattner A, Kozak N, Lassry Y, Sokolovskaya N. Primary intestinal T-cell lymphoma and sclerosing cholangitis: a cytokine-mediated association? J Intern Med 1998; 244: 537–41.

    PubMed  CAS  Google Scholar 

  207. Broome U, Hultcrantz R, Lefvert AK, Yi Q. Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis. Dis Colon Rectum 1998; 41: 1543–9.

    PubMed  CAS  Google Scholar 

  208. Sutherland LR, Martin F, Bailey RJ et al. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn’s disease. The Canadian Mesalamine for Remission of Crohn’s Disease Study Group. Gastroenterology 1997; 112: 1069–77.

    PubMed  CAS  Google Scholar 

  209. Bansal AS, Thomson A, Steadman C et al. Serum levels of interleukins 8 and 10, interferon gamma, granulocytemacrophage colony stimulating factor and soluble CD23 in patients with primary sclerosing cholangitis. Autoimmunity 1997; 26: 223–9.

    PubMed  CAS  Google Scholar 

  210. Stimpson SA, Dalldorf FG, Otterness IG, Schwab JH. Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide. J Immunol 1988; 140: 2964–9.

    PubMed  CAS  Google Scholar 

  211. Stimpson SA, Dalldorf FG, Otterness IG, Schwab JH. Pain and reactivation of arthritis induced by recombinant cytokines in rat ankles previously injured by peptidoglycan polysaccharide. Arthritis Rheum 1988; 31: S49.

    Google Scholar 

  212. Brandes ME, Allen JB, Ogawa H, Wahl SM. Transforming growth factor bI suppresses acute and chronic arthritis in experimental animals. J Clin Invest 1991; 87: 1108–13.

    PubMed  CAS  Google Scholar 

  213. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 2000; 106: 1481–8.

    PubMed  CAS  Google Scholar 

  214. Schulte CM, Dignass AU, Goebell H, Roher HD, Schulte KM. Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterology 2000; 119: 909–20.

    PubMed  CAS  Google Scholar 

  215. Tatakis DN, Guglielmoni P. HLA-B27 transgenic rats are susceptible to accelerated alveolar bone loss. J Periodontol. 2000; 71: 1395–400.

    PubMed  CAS  Google Scholar 

  216. Mano Y, Ishii M, Okamoto H, Igarashi T, Kobayashi K, Toyota T. Effect of tumor necrosis factor alpha on intrahepatic bile duct epithelial cell of rat liver. Hepatology 1996; 23: 1602–7.

    PubMed  CAS  Google Scholar 

  217. Strazzabosco M, Spirli C, Okolicsanyi L. Pathophysiology of the intrahepatic biliary epithelium. J Gastroenterol Hepatol 2000; 2000; 15: 244–53.

    PubMed  CAS  Google Scholar 

  218. Reynoso-Paz S, Coppel RL, Mackay IR, Bass NM, Ansari AA, Gershwin ME. The immunobiology of bile and biliary epithelium. Hepatology 1999; 30: 351–7.

    PubMed  CAS  Google Scholar 

  219. Ponsioen CY, Kuiper H, Ten Kate FJ, van Milligen d, van Deventer SJ, Tytgat GN. Immunohistochemical analysis of inflammation in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 1999; 11: 769–74.

    PubMed  CAS  Google Scholar 

  220. Tjandra K, Sharkey KA, Swain MG. Progressive development of Thl-type hepatic cytokine profile in rats with experimental cholangitis. Hepatology 2000; 31: 280–90.

    PubMed  CAS  Google Scholar 

  221. Berg PA, Klein R, Rocken M. Cytokines in primary biliary cirrhosis. Semin Liver Dis 1997; 17: 115–23.

    PubMed  CAS  Google Scholar 

  222. Broome U, Hultcrantz R, Scheynius A. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis. Scand J Gastroenterol 1993; 28: 126–30.

    PubMed  CAS  Google Scholar 

  223. Himeno H, Saibara T, Onishi S, Yamamoto Y, Enzan H. Administration of interleukin-2 induces major histocompatibility complex class II expression on the biliary epithelial cells, possibly through endogenous interferon-gamma production. Hepatology 1992; 16: 409–17.

    PubMed  CAS  Google Scholar 

  224. Ayres RC, Neuberger JM, Shaw J, Joplin R, Adams DH. Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of proinflamma tory cytokines. Gut 1993; 34: 1245–9.

    PubMed  CAS  Google Scholar 

  225. Cruickshank SM, Southgate J, Selby PJ, Trejdosiewicz LK. Expression and cytokine regulation of immune recognition elements by normal human biliary epithelial and established liver cell lines in vitro. J Hepatol 1998; 29: 550–8.

    PubMed  CAS  Google Scholar 

  226. Leon MR Bassendine MF, Gibbs P, Thick M, Kirby JA. Immunogenicity of biliary epithelium: study of the adhesive interaction with lymphocytes. Gastroenterology 1997; 112: 968–77.

    PubMed  CAS  Google Scholar 

  227. Cruickshank SM, Southgate J, Selby PJ, Trejdosiewicz LK. Inhibition of T cell activation by normal human biliary epithelial cells. J Hepatol 1999; 31: 1026–33.

    PubMed  CAS  Google Scholar 

  228. Jung HC, Eckmann L, Yang SK et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995; 95: 55–65.

    PubMed  CAS  Google Scholar 

  229. Jobin C, Sartor RB. The I kappa B/NF-kappa B system: a key determinant of mucosal inflammation and protection. Am J Physiol Cell Physiol 2000; 278: C451–62.

    PubMed  CAS  Google Scholar 

  230. Smeets TJ, Dolhain RJ, Breedveld FC Tak PP. Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis. J Pathol 1998; 186: 75–81.

    PubMed  CAS  Google Scholar 

  231. Palombella VJ, Conner EM, Fuseler JW et al. Role of the protcasome and NF-kappaB in strcptococcal cell wall-induced polyarthritis. Proc Natl Acad Sci USA 1998; 95: 15671–6.

    PubMed  CAS  Google Scholar 

  232. McCall RD, Haskill S, Zimmermann EM, Lund PK, Thompson RC, Sartor RB. Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology 1994; 106: 960–72.

    PubMed  CAS  Google Scholar 

  233. Herfarth HH, Bocker U, Janardhanam R, Sartor RB. Subtherapeutic corticosteroids potentiate the ability of interleukin 10 to prevent chronic inflammation in rats. Gastroenterology 1998; 115: 856–65.

    PubMed  CAS  Google Scholar 

  234. Stadnicki A, Sartor RB, Janardham R et al. Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats. FASEB J 1998; 12: 325–33.

    PubMed  CAS  Google Scholar 

  235. Yocum DE, Allen JB, Wahl SM, Calandra GB, Wilder RL. Inhibition by cyclosporin A of streptococcal cell wall-induced arthritis and hepatic granulomas in rats. Arthritis Rheum 1986; 29: 262–73.

    PubMed  CAS  Google Scholar 

  236. Van den Bosch F, Kruithof E, De Vos M, De Keyser F, Mielants H. Crohn’s disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms. Lancet 2000; 356: 1821–2.

    PubMed  Google Scholar 

  237. Taurog JD, Maika SD, Satumtira N et al. Inflammatory disease in HLA-B27 transgenic rats. Immunol Rev 1999; 169: 209–23.

    PubMed  CAS  Google Scholar 

  238. Morteau O, Morham SG, Sellon R et al. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J Clin Invest 2000; 105: 469–78.

    PubMed  CAS  Google Scholar 

  239. Salmi M, Rajala P, Jalkanen S. Homing of mucosal leukocytes to joints. Distinct endothelial ligands in synovium mediate leukocyte-subtype specific adhesion. J Clin Invest 1997; 99: 2165–72.

    PubMed  CAS  Google Scholar 

  240. Wahl SM, Hunt DA, Allen JB, Wilder RL, Paglia L, Hand AR. Bacterial cell wall-induced hepatic granulomas. An in vivo model of T cell-dependent fibrosis. J Exp Med 1986; 163: 884–902.

    PubMed  CAS  Google Scholar 

  241. Breban M, Fernandez-Sueiro JL, Richardson JA et al. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol 1996; 156: 794–803.

    PubMed  CAS  Google Scholar 

  242. Ohta K, Yamagami S, Taylor AW, Streilein JW. IL-6 antagonizes TGF-beta and abolishes immune privilege in eyes with endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 2000; 41: 2591–9.

    PubMed  CAS  Google Scholar 

  243. Marie O, Thillaye-Goldenberg B, Naud MC, de Kozak Y. Inhibition of endotoxin-induced uveitis and potentiation of local TNF-alpha and interleukin-6 mRNA expression by interleukin-13. Invest Ophthalmol Vis Sci 1999; 40: 2275–82.

    PubMed  CAS  Google Scholar 

  244. Llorente L, Richaud-Patin Y, Alvarado C, Reyes E, Alcocer-Varela J, Orozco-Topete R. Elevated Thl cytokine mRNA in skin biopsies and peripheral circulation in patients with erythema nodosum. Eur Cytokine Netw 1997; 8: 67–71.

    PubMed  CAS  Google Scholar 

  245. Moraes MO, Sarno EN, Teles RM et al. Anti-inflammatory drugs block cytokine mRNA accumulation in the skin and improve the clinical condition of reactional leprosy patients. J Invest Dermatol 2000; 115: 935–41.

    PubMed  CAS  Google Scholar 

  246. Sternberg EM, Hill JM, Chrousos GP et al. Inflammatory mediator-induced hypothalamic pituitary adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA 1989; 86: 2374–8.

    PubMed  CAS  Google Scholar 

  247. Bristol LA, Durum SK, Eisenberg SP. Differential regulation of group A streptococcal peptidoglycan-polysaccharide (PG-APS)-stimulated macrophage production of IL-1 by rat strains susceptible and resistant to PG-APS-induced arthritis. Cell Immunol 1993; 149: 130–43.

    PubMed  CAS  Google Scholar 

  248. Skaleric U, Allen JB, Mergenhagen SE, Wahl SM. Inhibitors of reactive oxygen intermediates suppress bacterial cell wall induced arthritis. J Immunol 1991; 147: 2559–64.

    PubMed  CAS  Google Scholar 

  249. McCall RD, Haskill JS, Sartor RB. Interleukin 1 and IL 1 receptor antagonist gene expression correlate with activity of inflammation in spontaneously relapsing enterocolitis in rats. Gastroenterology 1991; 100: 766A (abstract).

    Google Scholar 

  250. Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992; 103: 1587–95.

    PubMed  CAS  Google Scholar 

  251. Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995; 154: 2434–40.

    PubMed  CAS  Google Scholar 

  252. Stokkers PC, van Aken BE, Basoski N, Reitsma PH, Tytgat GN, van Deventer SJ Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut 1998; 43: 33–9.

    PubMed  CAS  Google Scholar 

  253. Lohmuller JL, Pemberton JH, Dozois RR, Ilstrup D, van Heerden J Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990; 211: 662–7.

    Google Scholar 

  254. Salemans JM, Nagengast FM, Lubbers EJ, Kuijpers JH. Postoperative and long-term results of ileal pouch-anal anastomosis for ulcerative colitis and familial polyposis coli. DigDisSci 1992; 37: 1882–9.

    CAS  Google Scholar 

  255. Helwig U, Rizzello F, Cifone G et al. Elevated IL-10 levels in pouch-tissue after probiotic therapy. Immunol Lett 1999; 69: 159 (abstract).

    Google Scholar 

  256. Gionchetti P, Rizzello F, Venturi A et al. Maintenance treatment of chronic pouchitis: a randomized placebo-controlled, double-blind trial with a new probiotic preparation. Gastroenterology 1998; 114: A985 (abstract).

    Google Scholar 

  257. Penna C, Dozois R, Tremaine W et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996; 38: 234–9.

    PubMed  CAS  Google Scholar 

  258. Chapman RW. Role of immune factors in the pathogenesis of primary sclerosing cholangitis. Semin Liver Dis 1991; 11: 1–4.

    PubMed  CAS  Google Scholar 

  259. Sartor RB, Green KD, Anderle SK. Spontaneously reactivating granulomatous enterocolitis with extraintestinal inflammation induced by bacterial cell wall polymers in genetically susceptible rats. Gastroenterology 1989; 96: 442A (abstract).

    Google Scholar 

  260. Braun J, Yin Z, Spiller I et al. Low secretion of tumor necrosis factor alpha, but no other Thl or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis. Arthritis Rheum 1999; 42: 2039–44.

    PubMed  CAS  Google Scholar 

  261. Schoppet M, Bubert A, Huppertz HI. Dendritic cell function is perturbed by Yersinia enterocolitica infection in vitro. Clin Exp Immunol 2000; 122: 316–23.

    PubMed  CAS  Google Scholar 

  262. MacDonald TT, Pettersson S. Bacterial regulation of intestinal immune responses. Inflam Bowel Dis 2000; 6: 116–22.

    CAS  Google Scholar 

  263. Nickerson CL, Lutha HS, David CS. Role of enterobacteria and HLA B27 in spondyloarthropathies: studies with transgenic mice. Ann Rheum Dis 1990; 49: 426–33.

    PubMed  CAS  Google Scholar 

  264. Falgarone G, Blanchard HS, Riot B, Simonet M, Breban M. Cytotoxic T-cell-mediated response against Yersinia pseudotuberculosis in HLA-B27 transgenic rat. Infect Immun 1999; 67: 3773–9.

    PubMed  CAS  Google Scholar 

  265. Stagg AJ, Breban M, Hammer RE, Knight SC, Taurog JD. Defective dendritic cell (DC) function in a HLA-B27 transgenic rat model of spondyloarthropathy (SpA). Adv Exp Med Biol 1995; 378: 557–9.

    PubMed  CAS  Google Scholar 

  266. Kingsbury DJ, Mear JP, Witte DP, Taurog JD, Roopenian DC, Colbert RA. Development of spontaneous arthritis in beta2-microglobulin-deficient mice without expression of HLA-B27: association with deficiency of endogenous major histocompatibility complex class I expression. Arthritis Rheum 2000; 43: 2290–6.

    PubMed  CAS  Google Scholar 

  267. Leirisalo-Repo M, Lauhio A, Repo H. Chemotaxis and chemiluminescence responses of synovial fluid polymorphonuclear leucocytes during acute reactive arthritis. Ann Rheum Dis 1990; 49: 615–19.

    PubMed  CAS  Google Scholar 

  268. Leirisalo-Repo M. Inflammation in HLA B27 associated diseases. Scand J Rheumatol Suppl. 1990; 87: 140–7.

    PubMed  CAS  Google Scholar 

  269. Tonkonogy SL, Hoentjen F, Sprengers D, Goerres M, Sartor RB, Dieleman LA. Altered profile of the immunoregulatory cytokines IL-10, IL-12 and IFN-gamma in HLA B27 transgenic rat mesenteric lymph node cells stimulated with cecal bacterial components. FASEB J 2001; 15: A372 (abstract).

    Google Scholar 

  270. Powell FC, Schroeter AL, Su WPD, Perry HO. Pyoderma gangrenosum: a review of 86 patients. J Q Med 1985; 217: 173–86.

    Google Scholar 

  271. Mitchell SA, Chapman RW. Primary sclerosing cholangitis. Clin Rev Allergy Immunol 2000; 28: 185–214.

    Google Scholar 

  272. Spurkland A, Saarinen S, Boberg KM et al. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Ant 1999; 53: 459–69.

    CAS  Google Scholar 

  273. Bernal W, Moloney M, Underhill J, Donaldson PT. Asso ciation of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol 1999; 30: 237–41.

    PubMed  CAS  Google Scholar 

  274. Donaldson PT, Norris S, Constantini PK, Bernal W, Harrison P, Williams R. The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no associations with disease susceptibility/resistance. J Hepatol 2000; 32: 882–6.

    PubMed  CAS  Google Scholar 

  275. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell 1990; 63: 1099–112.

    PubMed  CAS  Google Scholar 

  276. Krug HE, Taurog JD. HLA-B27 has no effect on the phenotypic expression of progressive ankylosis in ank/ank mice. J Rheumatol 2000; 27: 1257–9.

    PubMed  CAS  Google Scholar 

  277. Alvarez I, Lopez dCJ HLA-B27 and immunogenetics of spondyloarthropathies. Curr Opin Rheumatol 2000; 12: 248–53.

    PubMed  CAS  Google Scholar 

  278. Lopez dCJ The pathogenetic role of HLA-B27 in chronic arthritis. Curr Opin Immunol 1998; 10: 59–66.

    Google Scholar 

  279. Edwards JC, Bowness P, Archer JR. Jekyll and Hyde: the transformation of HLA-B27. Immunol Today 2000; 21: 256–60.

    PubMed  CAS  Google Scholar 

  280. Weiss EH, Schliesser G, Botteron C et al. HLA class I transgenic mice as model system to study MHC restricted antigen recognition in man. Scand J Rheumatol 1990; 87: 91–6.

    CAS  Google Scholar 

  281. Orchard TR, Thiyagaraja S, Welsh KI, Wordsworth BP, Hill GJ, Jewell DP. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 2000; 118: 274–8.

    PubMed  CAS  Google Scholar 

  282. de la Concha EG, Fernandez-Arquero M, Lopez-Nava G et al. Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL. Gastroenterology 2000; 119: 1491–5.

    PubMed  Google Scholar 

  283. Yeon HB, Lindor NM, Seidman JG, Seidman CE. Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet 2000; 66: 1443–8.

    PubMed  CAS  Google Scholar 

  284. van Hoogstraten HJ, Wolfhagen FH, van de Meeberg PC et al. Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses. J Hepatol 1998; 29: 417–23.

    PubMed  Google Scholar 

  285. LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL, Beaver SJ, Zinsmeister AR. Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology 1988; 95: 1036–42.

    PubMed  CAS  Google Scholar 

  286. Gunnarsson I, Kanerud L, Pettersson E, Lundberg I, Lindblad S, Ringertz B. Predisposing factors in sulphasalazine-induced systemic lupus erythematosus. Br J Rheumatol 1997; 36: 1089–94.

    PubMed  CAS  Google Scholar 

  287. Adibi SA, Stanko RT. Perspectives on gastrointestinal surgery for treatment of morbid obesity: the lesson learned. Gastroenterology 1984; 87: 1381–91.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    R. Balfour Sartor (Professor of Medicine)

  2. University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    Steven N. Lichtman (Professor of Pediatrics)

Authors
  1. R. Balfour Sartor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven N. Lichtman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cedars-Sinai IBD Center, Los Angeles, CA, USA

    Stephan R. Targan  & Loren C. Karp  & 

  2. Cork University Hospital, Cork, Ireland

    Fergus Shanahan

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Kluwer Academic Publishers

About this chapter

Cite this chapter

Sartor, R.B., Lichtman, S.N. (2003). Mechanisms of systemic inflammation associated with intestinal injury. In: Targan, S.R., Shanahan, F., Karp, L.C. (eds) Inflammatory Bowel Disease: From Bench to Bedside. Springer, Boston, MA. https://doi.org/10.1007/0-387-25808-6_16

Download citation

  • DOI: https://doi.org/10.1007/0-387-25808-6_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-25807-2

  • Online ISBN: 978-0-387-25808-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation